Walgreens has been sued by Arkansas Attorney General Leslie Rutledge, and the case was filed earlier this week. In her filing, she claimed that the pharmacy chain company played a big part in making the opioid crisis situation in the state worse.
Rutledge accused Walgreens of rendering a large number of orders for painkillers, and most of them are suspicious. The lawyer said that this is a violation of Arkansas’ Deceptive Trade Practices Act.
The lawsuit against Walgreens
The lawsuit was filed in Pulaski County Court, and it was stated that the pharmacy did not do enough to make sure that the prescriptions are legitimate and not questionable. It was said that because of Walgreens' failure to monitor the orders, large amounts of the regulated drug were distributed in Arkansas, as per Arkansas Democrat Gazelle.
"Walgreens has a legal responsibility to report suspicious orders and suspicious prescriptions," the attorney general said. "By failing to do so they enabled the black market of prescription drugs to increase dramatically, thus leading to more, greater addiction and more lives lost in the state of Arkansas."
As stated in the lawsuit, from 2006 to 2014, Walgreens fulfilled orders of over 142 million dosages of oxycodone and hydrocodone in the state. Rutledge said that this big amount should have alerted the company to the fact that suspicious orders were being placed.
It was added that such quantities that were distributed in Arkansas far exceeded the normal amount that could be consumed for medical legit purposes. “Walgreens failed to report and halt those orders and instead increased the number of pills distributed,” the statement from the suit reads.
With the filing, the state is seeking a directive that will force Walgreens to act responsibly and comply with federal and state laws. It is also seeking appropriate civil penalties for every violation that the company may have committed against the state’s consumer protection laws.
Walgreens denies the allegations
Walgreens refuted the accusations and stated that it never produced or marketed opioids. The company’s spokesperson further told FOX Business that they never sold the said drug to pain clinics, online pharmacies, and 'pill mills' that worsened the opioid crisis.
"Prior to 2014, we delivered opioids only to our own pharmacies, and the only place we ever sold FDA-approved opioid medications was at the pharmacy counter when presented with valid prescriptions written by DEA-licensed physicians for legitimate medical needs," the firm’s spokesperson said.
Finally, he added that the company’s pharmacists always evaluate and take the law into consideration before deciding whether to fill a prescription for controlled substances.


Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing
Robinhood Expands Sports Event Contracts With Player Performance Wagers
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure
United Airlines Flight to Tokyo Returns to Dulles After Engine Failure During Takeoff
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute 



